Effect of Blood Transfusion in Covid-19
Not Applicable
Recruiting
- Conditions
- Respiratory status of patients with Covid 19.COVID-19, virus identifiedU07.1
- Registration Number
- IRCT20201003048904N1
- Lead Sponsor
- Boushehr University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Confirmation of Covid 19
The patient's clinical condition confirms the indication for hospitalization.
Chest CT scan shows more than 25% of pulmonary involvement.
SPO2 equal to or less than 94% on the day of admission
Hemoglobin should be less than 12 g / dl (women) and less than 13 g / dl (men) on the day of admission.
Absence of absolute or partial contraindications including history of allergies, anaphylaxis, history of thrombosis, pregnancy
Satisfaction of the patient or his/her legal companions to participate in the study
Exclusion Criteria
Contraindications for receiving blood.
The patient's unwillingness to receive blood.
The need to receive blood as a treatment in the course of the disease for other reasons.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood oxygen saturation. Timepoint: Admission day, The first day after the blood transfusion, The third day after the blood transfusion. Method of measurement: Pulse oximetry.
- Secondary Outcome Measures
Name Time Method Dyspnea status. Timepoint: Admission day, The first day after the blood transfusion, The third day after the blood transfusion. Method of measurement: Subjective: question from the patient. Objective: respiratory rate count in a minute.